LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) Operating cash flow 2016–2025
LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$206,000FY2025 · since FY2016: $20.8M → -$206,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$206,000 | -180.2% |
| FY2024 | $257,000 | +101.5% |
| FY2023 | -$17.4M | +22.8% |
| FY2022 | -$22.6M | -237.2% |
| FY2021 | $16.5M | +196.7% |
| FY2020 | -$17.0M | -206.4% |
| FY2019 | $16.0M | -19.0% |
| FY2018 | $19.8M | -33.7% |
| FY2017 | $29.8M | +43.7% |
| FY2016 | $20.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More LFCR financial trends
LFCR RevenueLFCR Net incomeLFCR Net marginLFCR Gross profitLFCR Gross marginLFCR Operating incomeLFCR Operating marginLFCR Free cash flowLFCR Capital expendituresLFCR Return on equityLFCR Stock buybacksLFCR Dividends paidLFCR Total assetsLFCR Total liabilitiesLFCR Shareholders’ equityLFCR overview →